** Shares of Microba Life Sciences MAP.AX fall 17.8% to A$0.185
** Stock set for its weakest session since October 23, 2023- if current trends hold
** Health sciences co posts a 15% decline in Q3 revenue compared to last year
** But, co sees FY25 revenue to be up 26%-34% from last year
** Co set for its strongest month since January
** About 559,491 shares change hands, 3.7x the 30-day average of 152,712 shares
** Stock down 5.1% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。